Ames, David
The University of Melbourne · National Ageing Research Institute
53 papers on CoChat
Most cited papers
- VerifiedRetracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet
Dementia and Cognitive Impairment ResearchAging, Health, and Disability
Cited by 10,430
- Verified
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 6,072
- Verified
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet
Dementia and Cognitive Impairment ResearchHearing Loss and Rehabilitation
Cited by 3,860
- Verified
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 2,279
- Verified
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 988
- Verified
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 986
- Verified
The genetic architecture of the human cerebral cortex
Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., Ching, C. R. K., McMahon, M. A. B., et al. (2020) · Science
Genetic Associations and EpidemiologyCognitive Abilities and Testing
Cited by 876
- Verified
Common genetic variants influence human subcortical brain structures
Initiative, T. A. D. N., Hibar, D. P., The CHARGE Consortium, EPIGEN, IMAGEN, SYS, Stein, J. L., Renteria, M. E., Arias-Vasquez, A., Desrivières, S., et al. (2015) · Nature
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 858
- Verified
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 833
- Verified
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 725
- Verified
The prevalence of anxiety in older adults: Methodological issues and a review of the literature
Bryant, C., Jackson, H., & Ames, D. (2008) · Journal of Affective Disorders
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access
Cited by 511
- Verified
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia
Brodaty, H., Ames, D., Snowdon, J., Woodward, M., Kirwan, J., Clarnette, R., Lee, E., Lyons, B., & Grossman, F. (2003) · The Journal of Clinical Psychiatry
Dementia and Cognitive Impairment ResearchSchizophrenia research and treatment
Cited by 464
- Verified
Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)
Davies, G., Armstrong, N., Bis, J. C., Bressler, J., Chouraki, V, Giddaluru, S., Hofer, E., Ibrahim-Verbaas, C. A., Kirin, M., Lahti, J., et al. (2015) · Molecular Psychiatry
Genetic Associations and EpidemiologyCognitive Abilities and Testing
Cited by 384
- Verified
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
Chételat, G., Villemagne, V. L., Bourgeat, P., Pike, K. E., Jones, G., Ames, D., Ellis, K. A., Szoeke, C., Martins, R. N., O'Keefe, G. J., et al. (2010) · Annals of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 373
- Verified
Novel genetic loci associated with hippocampal volume
Hibar, D. P., Adams, H. H. H., Jahanshad, N., Chauhan, G., Stein, J. L., Hofer, E., Renteria, M. E., Bis, J. C., Arias-Vasquez, A., Ikram, M. K., et al. (2017) · Nature Communications
Genetic Associations and EpidemiologyMemory and Neural Mechanisms
Cited by 299
- Verified
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V, Rowe, C. C., Lance Macaulay, S., Szoeke, C., et al. (2013) · Translational Psychiatry
Dementia and Cognitive Impairment ResearchRetinal Imaging and Analysis
Cited by 297
- Verified
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
Zhang, Q., Sidorenko, J., Couvy-Duchesne, B., Marioni, R. E., Wright, M. J., Goate, A. M., Marcora, E., Huang, K.-L., Porter, T., Laws, S. M., et al. (2020) · Nature Communications
Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology
Cited by 272
- Verified
Dementia and caregiver burden: A three‐year longitudinal study
Connors, M. H., Seeher, K., Teixeira‐Pinto, A., Woodward, M., Ames, D., & Brodaty, H. (2020) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchNursing care and research
Cited by 265
- Verified
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 255
- Verified
Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 247
- Verified
Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards
O'Connor, D. W., Ames, D., Gardner, B., & King, M. (2009) · International Psychogeriatrics
Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes
Cited by 239
- Verified
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
Brown, B. M., Peiffer, J. J., Taddei, K., Lui, J. K., Laws, S. M., Gupta, V. B., Taddei, T., Ward, V. K., Rodrigues, M. A., Burnham, S., et al. (2013) · Molecular Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 235
- Verified
Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
Rowe, C. C., Bourgeat, P., Ellis, K. A., Brown, B., Lim, Y. Y., Mulligan, R., Jones, G., Maruff, P., Woodward, M., Price, R., et al. (2013) · Annals of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 222
- Verified
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
Bourgeat, P., Chételat, G., Villemagne, V. L., Fripp, J., Raniga, P., Pike, K., Acosta, O., Szoeke, C., Ourselin, S., Ames, D., et al. (2010) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 220
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free